"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."

During the past decade, Aspirus Wausau Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Wausau Hospital" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "AtriCure, Inc." with 3 trials sponsored, "Aspirus Heart and Vascular Institute-Research and Education" with 2 trials sponsored, "CVRx, Inc." with 1 trials sponsored and "HealthCore-NERI" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Wausau Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Aspirus Wausau Hospital" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Wausau Hospital" are "Heart Failure" (4 trials), "Bradycardia" (2 trials), "AFib" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Aspirus Wausau Hospital" in a lesser frequency.

Most popular intervention types in "Aspirus Wausau Hospital" are "Device" (10 trials), "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anticoagulation Therapy" (1 trials), "AtriClip LAA Exclusion Device" (1 trials), "AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems" (1 trials), "Aveir DR Leadless Pacemaker System" (1 trials) and "BAROSTIM NEO System and Medical Management" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Wausau Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Aspirus Wausau Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Aspirus Wausau Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Wausau Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".